Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>…interestingly no less an authority than josh berger himself posted a slide including polymerase inhibitors with telaprivir as the future of HCV therapy<

The JPM webcast was the first time I heard Boger mention the polymerase-inhibitor class explicitly. Boger chooses his words carefully, so maybe this is significant.